Conduit Historical Balance Sheet
| CDTTW Stock | 0.01 0 17.05% |
Trend analysis of Conduit Pharmaceuticals balance sheet accounts such as Short Long Term Debt Total of 1.3 B, Other Current Liabilities of 322.3 M or Total Current Liabilities of 653.8 M provides information on Conduit Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Conduit Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Conduit Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Conduit Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Conduit Pharmaceuticals is a good buy for the upcoming year.
Conduit |
About Conduit Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Conduit Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Conduit Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Conduit Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Conduit currently owns. An asset can also be divided into two categories, current and non-current.
Conduit Pharmaceuticals Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Conduit Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Conduit Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Conduit Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Conduit Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most accounts from Conduit Pharmaceuticals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Conduit Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Conduit Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Conduit Stock please use our How to Invest in Conduit Pharmaceuticals guide.At this time, Conduit Pharmaceuticals' Non Currrent Assets Other are fairly stable compared to the past year. Cash And Short Term Investments is likely to climb to about 388.8 M in 2025, whereas Capital Stock is likely to drop 4,767 in 2025.
| 2022 | 2023 | 2024 | 2025 (projected) | Short and Long Term Debt Total | 2.0M | 985K | 1.2B | 1.3B | Total Assets | 5K | 7.2M | 3.3B | 3.4B |
Conduit Pharmaceuticals balance sheet Correlations
Click cells to compare fundamentals
Conduit Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Conduit Stock Analysis
When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.